Upendra K. Marathi
Directeur Général chez 7 Hills Pharma LLC
Provenance du réseau au premier degré de Upendra K. Marathi
Entité | Type d'entité | Industrie | |
---|---|---|---|
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology 7 Hills Pharma LLC is a clinical-stage pharmaceutical company based in Houston, TX. The private company is developing first-in-concept integrin activators to augment immunotherapies for the treatment of drug-resistant solid tumors and infectious diseases. The lead compound, 7HP349, is an oral VLA-4/LFA-1 allosteric activator that will be in phase I testing for PD-1 refractory solid tumors and geriatric influenza. The company's compounds are expected to augment antigen presentation and immune priming to facilitate a productive immune response against a variety of antigens. 7 Hills Pharma is managed by an experienced group of pharmaceutical executives, including Richard A. F. Dixon, Upendra K. Marathi, Kala Marathi, Peter Vanderslice, and Darren Woodside. Upendra K. Marathi has been the CEO since incorporation.
3
| Private Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Upendra K. Marathi via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | General Counsel | |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BioTransplant, Inc.
BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Pharmaceuticals: Major | Director/Board Member | |
ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Reliant Energy Net Ventures, Inc. | Private Equity Investor | ||
Extropy Pharmaceuticals, Inc. | Chief Executive Officer | ||
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Texas A&M University | College/University | Undergraduate Degree | |
University of Guelph | College/University | Doctorate Degree | |
Wellesley College | College/University | Undergraduate Degree | |
Baylor College of Medicine | College/University | Doctorate Degree | |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Biotechnology | Corporate Officer/Principal | |
Texas Lyceum
Texas Lyceum Miscellaneous Commercial ServicesCommercial Services Texas Lyceum promotes education for directors by identifying and exploring the interrelationships of major issues. The non-profit company is based in Dallas, TX. | Miscellaneous Commercial Services | Director/Board Member | |
XENO TRANSPLANTS CORPORATION | Biotechnology | Chairman | |
GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz Pharmaceuticals Corp. | General Counsel | ||
AVITA Medical Pty Ltd.
AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Chief Executive Officer | |
Merck Sharp & Dohme Research Laboratories | Director/Board Member | ||
C. T. Bauer College of Business | College/University | Corporate Officer/Principal | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
National Association of Women Mbas
National Association of Women Mbas Miscellaneous Commercial ServicesCommercial Services The National Association of Women MBAs is a non-profit organization that aims to empower female business professionals. | Miscellaneous Commercial Services | Director/Board Member | |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Private Equity Investor | |
Harvard Business School | College/University | Graduate Degree | |
Climate Impact Capital LLC
Climate Impact Capital LLC Investment ManagersFinance Climate Impact Capital LLC (Climate Impact Capital) is a venture capital firm founded in 2016 by Alexander Rozenfeld. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Investor | |
Cougar Venture
Cougar Venture Investment ManagersFinance Cougar Venture (Cougar Venture) is a venture capital division of C. T. Bauer College of Business founded in 2008. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Investor | |
Ontario Veterinary College | College/University | Doctorate Degree | |
ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Gamida Cell, Inc.
Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Biotechnology | Director/Board Member | |
AVITA MEDICAL, INC. | Medical Specialties | Chief Executive Officer | |
The Houston Angel Network
The Houston Angel Network Investment ManagersFinance The Houston Angel Network functions as an alternative investment manager. The private company is based in Houston, TX. | Investment Managers | Private Equity Investor | |
TeXchange LLC
TeXchange LLC Miscellaneous Commercial ServicesCommercial Services TeXchange LLC is a community of business leaders, entrepreneurs, investors, and advisors who promote the entrepreneurial environment in Austin, TX, and help develop the next generation of leaders for growing companies in central Texas. The company organizes events that bring together passionate people who want to share ideas on what ’ s current in the central Texas business community, learn from subject matter experts, and connect with potential collaborators. TeXchange carefully selects sponsors who are local businesses that serve Austin’s technology sector. The company provides a platform for knowledge-sharing, development, and networking for founders, business leaders, investors, and executives at the middle stages of their careers and company trajectories. | Miscellaneous Commercial Services | Director/Board Member | |
Highgate Technology Ventures
Highgate Technology Ventures Investment ManagersFinance Highgate Technology Ventures (Highgate Ventures) is a private equity and venture capital subsidiary of TCP Highgate Holdings SPV LLC headquartered in New York. | Investment Managers | Chief Investment Officer |
Statistiques
Internationale
Etats-Unis | 38 |
Canada | 4 |
Suisse | 2 |
Royaume-Uni | 2 |
Australie | 2 |
Sectorielle
Health Technology | 18 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 5 |
Transportation | 2 |
Opérationnelle
Director/Board Member | 12 |
Corporate Officer/Principal | 10 |
Private Equity Investor | 7 |
Independent Dir/Board Member | 6 |
Chief Executive Officer | 5 |
Relations les plus connectées
Insiders | |
---|---|
Michael Perry | 28 |
Kala Marathi | 13 |
Richard A. F. Dixon | 5 |
- Bourse
- Insiders
- Upendra K. Marathi
- Connexions Sociétés